Innovative MedTech Inc. (IMTH)
USD 0.4
(0.0%)
USD 0.4
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 1.76 Million USD | 2.91% |
| 2023 | 2.02 Million USD | -1.06% |
| 2022 | 2.04 Million USD | 13.17% |
| 2021 | 1.8 Million USD | -37.03% |
| 2020 | 2.86 Million USD | 179.3% |
| 2019 | 1.02 Million USD | 0.0% |
| 2014 | 744.35 Thousand USD | 24.46% |
| 2013 | 598.04 Thousand USD | 36.42% |
| 2012 | 438.39 Thousand USD | -46.27% |
| 2011 | 815.99 Thousand USD | -43.24% |
| 2010 | 1.43 Million USD | 276.42% |
| 2009 | 381.93 Thousand USD | -64.11% |
| 2008 | 1.06 Million USD | -29.39% |
| 2007 | 1.5 Million USD | 137.69% |
| 2006 | 634.07 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 2.08 Million USD | 3.28% |
| 2024 Q2 | 3.69 Million USD | 77.02% |
| 2024 Q3 | 3.63 Million USD | -1.64% |
| 2024 Q4 | 1.76 Million USD | -42.77% |
| 2023 FY | 2.02 Million USD | -1.06% |
| 2023 Q4 | 2.02 Million USD | 0.69% |
| 2023 Q1 | 2.14 Million USD | 5.12% |
| 2023 Q2 | 2.14 Million USD | -0.21% |
| 2023 Q3 | 2 Million USD | -6.33% |
| 2022 Q4 | 2.04 Million USD | 5.18% |
| 2022 FY | 2.04 Million USD | 13.17% |
| 2022 Q3 | 1.94 Million USD | -0.52% |
| 2022 Q2 | 1.95 Million USD | -3.36% |
| 2022 Q1 | 2.02 Million USD | 11.92% |
| 2021 Q3 | 1.84 Million USD | 0.0% |
| 2021 FY | 1.8 Million USD | -37.03% |
| 2021 Q1 | 767.00 USD | 0.0% |
| 2021 Q4 | 1.8 Million USD | -2.33% |
| 2020 FY | 2.86 Million USD | 179.3% |
| 2019 FY | 1.02 Million USD | 0.0% |
| 2015 Q1 | 744.35 Thousand USD | 14.86% |
| 2014 Q1 | 598.04 Thousand USD | 19.68% |
| 2014 Q2 | 631.9 Thousand USD | 5.66% |
| 2014 Q3 | 636.31 Thousand USD | 0.7% |
| 2014 Q4 | 648.04 Thousand USD | 1.84% |
| 2014 FY | 744.35 Thousand USD | 24.46% |
| 2013 FY | 598.04 Thousand USD | 36.42% |
| 2013 Q2 | 415.4 Thousand USD | -5.25% |
| 2013 Q1 | 438.39 Thousand USD | -39.16% |
| 2013 Q4 | 499.7 Thousand USD | 8.01% |
| 2013 Q3 | 462.64 Thousand USD | 11.37% |
| 2012 Q1 | 815.99 Thousand USD | -2.21% |
| 2012 Q2 | 812.11 Thousand USD | -0.48% |
| 2012 Q3 | 699.43 Thousand USD | -13.87% |
| 2012 Q4 | 720.53 Thousand USD | 3.02% |
| 2012 FY | 438.39 Thousand USD | -46.27% |
| 2011 FY | 815.99 Thousand USD | -43.24% |
| 2011 Q2 | 1.49 Million USD | 3.85% |
| 2011 Q3 | 908.24 Thousand USD | -39.17% |
| 2011 Q4 | 834.48 Thousand USD | -8.12% |
| 2011 Q1 | 1.43 Million USD | 38.9% |
| 2010 FY | 1.43 Million USD | 276.42% |
| 2010 Q2 | 380.46 Thousand USD | -0.39% |
| 2010 Q1 | 381.93 Thousand USD | -59.99% |
| 2010 Q3 | 587.68 Thousand USD | 54.47% |
| 2010 Q4 | 1.03 Million USD | 76.13% |
| 2009 Q3 | 966.11 Thousand USD | -2.86% |
| 2009 FY | 381.93 Thousand USD | -64.11% |
| 2009 Q4 | 954.64 Thousand USD | -1.19% |
| 2009 Q1 | 1.06 Million USD | 15.62% |
| 2009 Q2 | 994.53 Thousand USD | -6.54% |
| 2008 Q2 | 1.55 Million USD | 2.97% |
| 2008 Q4 | 920.39 Thousand USD | 2.91% |
| 2008 FY | 1.06 Million USD | -29.39% |
| 2008 Q1 | 1.5 Million USD | 13.71% |
| 2008 Q3 | 894.36 Thousand USD | -42.37% |
| 2007 Q2 | 942.4 Thousand USD | 48.63% |
| 2007 Q3 | 1.09 Million USD | 16.44% |
| 2007 FY | 1.5 Million USD | 137.69% |
| 2007 Q4 | 1.32 Million USD | 20.79% |
| 2007 Q1 | 634.07 Thousand USD | 25.8% |
| 2006 Q3 | 533.14 Thousand USD | 13.91% |
| 2006 Q2 | 468.02 Thousand USD | 0.0% |
| 2006 Q4 | 504.02 Thousand USD | -5.46% |
| 2006 FY | 634.07 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -267.936% |
| Ansell Limited | -54.99 Million USD | 103.209% |
| Ansell Limited | -55.1 Million USD | 103.203% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 104.836% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 1779.07% |
| Psykey, Inc. | 634.59 Thousand USD | -178.089% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.853% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.853% |
| Encision Inc. | 1.29 Million USD | -36.728% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 23.562% |
| LifePoint, Inc. | -3.26 Million USD | 154.066% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 64.016% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 18.375% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 4175.226% |
| Reflect Scientific, Inc. | -1.03 Million USD | 270.455% |
| SmileDirectClub, Inc. | 778.67 Million USD | 99.773% |
| Sector 10, Inc. | 163 Thousand USD | -982.66% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.423% |
| SheerVision, Inc. | 57.34 Thousand USD | -2977.187% |
| United Health Products, Inc. | 660.56 Thousand USD | -167.154% |
| Vasamed, Inc. | 22.12 Thousand USD | -7877.29% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 32.931% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -128.51% |